Shopping Cart
- Remove All
- Your shopping cart is currently empty
WCA-814, an androgen receptor (AR) antagonist-Hsp90 inhibitor conjugate, induces degradation of both full-length and AR-V7, exhibiting cytotoxic effects in prostatic cancer cells with half maximal inhibitory concentrations (IC50) of 171.2 nM and 26.5 nM for LNCaP and 22Rv1 cells, respectively [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | WCA-814, an androgen receptor (AR) antagonist-Hsp90 inhibitor conjugate, induces degradation of both full-length and AR-V7, exhibiting cytotoxic effects in prostatic cancer cells with half maximal inhibitory concentrations (IC50) of 171.2 nM and 26.5 nM for LNCaP and 22Rv1 cells, respectively [1]. |
Molecular Weight | 861.43 |
Formula | C46H53ClN10O5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.